Lưu ý: Thang điểm này chỉ có giá trị tham khảo. Việc đưa ra quyết định dựa vào đặc điểm của từng bệnh nhân và có sự thảo luận giữa các chuyên khoa liên quan cũng như bệnh nhân và người nhà. Không tự ý sử dụng thuốc không theo đơn và không có sự tư vấn của bác sĩ.

1. Mihatov N, Secemsky EA, Kereiakes DJ, et al. Individualizing dual antiplatelet therapy (DAPT) duration based on bleeding risk, ischemic risk, or both: An analysis from the DAPT Study. PLoS One. 2017;12(9):e0174502. PubMed

2. Toyota T, Shiomi H, Morimoto T, et al. Short versus prolonged dual antiplatelet therapy duration after coronary stent implantation: Comparison between the DAPT study and nine other trials. Ir J Med Sci. 2023;192(4):1645–1647. PubMed

3. Srinivasan SB, Sehly A, Jaltotage B, et al. Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: A 5-year population-based cohort study. Open Heart. 2022;9(2):e001999. PubMed

4. Pufulete M, Harris J, Pouwels K, et al. Real-world bleeding in patients with acute coronary syndrome undergoing PCI and prescribed different DAPT combinations: A population-based cohort study emulating a target trial. Int J Cardiol Heart Vasc. 2021;33:100750. PubMed

5. Wernly B, Rezar R, Gurbel PA, Jung C. Short-term DAPT followed by P2Y12 inhibitor monotherapy versus traditional DAPT after PCI: Meta-analysis and viewpoint. J Thromb Thrombolysis. 2020;49(1):173–176. PubMed

6. Tian J, Wang Z, Wang Y, et al. Rationale and design of dual antiplatelet therapy in patients with coronary multivessel disease (DAPT-MVD): A multicenter randomized controlled trial. Clin Cardiol. 2024;47(12):e70049. PubMed

7. Park DY, An S, Kumar A, et al. Abbreviated versus standard duration of DAPT after PCI: A systematic review and network meta-analysis. Am J Cardiovasc Drugs. 2022;22(6):633–645. PubMed

8. Kwok CS, Wong CW, Nagaraja V, Mamas MA. A systematic review of studies evaluating the performance of the DAPT score. Int J Cardiol. 2016;221:937–944. PubMed

9. Qamar U, Naeem F, Maqsood MT, et al. Efficacy and safety of ticagrelor monotherapy following short DAPT vs prolonged 12-month DAPT in ACS patients post-PCI: A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2024;80(12):1871–1882. PubMed

10. Calcagno S, Lucisano L, Mancone M, et al. Bleeding versus thrombosis: Role of short DAPT in complex coronary lesions. Minerva Cardioangiol. 2015;63(6):533–546. PubMed

11. Elmariah S. Formal comment on short versus prolonged DAPT duration after coronary stenting. PLoS One. 2017;12(9):e0184513. PubMed

12. Jang JY, Shin DH, Kim JS, et al. Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome. PLoS One. 2018;13(11):e0207386. PubMed

13. Yoo J, Lim H, Seo KD. Optimal duration of dual antiplatelet therapy after carotid artery stenting: A nationwide cohort study. Stroke. 2025;56(3):613–620. PubMed

14. Piccolo R, Gargiulo G, Franzone A, et al. Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention. Ann Intern Med. 2017;167(1):17–25. PubMed

15. Kereiakes DJ, Yeh RW, Massaro JM, et al. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. J Am Coll Cardiol. 2016;67(21):2492–2502. PubMed

16. Yoshikawa Y, Shiomi H, Watanabe H, et al. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese PCI Studies. Circulation. 2018;137(6):551–562. PubMed

17. Banerjee S, Angiolillo DJ, Boden WE, et al. Use of antiplatelet therapy/DAPT for post-PCI patients undergoing noncardiac surgery. J Am Coll Cardiol. 2017;69(14):1861–1870. PubMed

18. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2016;68(10):1082–1115. PubMed